Sort
64,565 grants matching “drug discovery”
Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis
$1,541,209William E. Carson · Ohio State University · UM1 · FY2019 · CA
Functional Analysis of Novel Genes in Eye Development and Vision
$1,540,291Graeme J Wistow · National Eye Institute · ZIA · FY2022 · EY
Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection
$1,540,258Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U2C · FY2025 · TR
A comprehensive platform for novel therapy development from the microbiome
$1,540,112Curtis Huttenhower · Broad Institute, Inc. · R24 · FY2020 · DK
Cancer Research Center of Hawaii
$1,540,105Michele Carbone · University Of Hawaii At Manoa · P30 · FY2010 · CA
Defining RAS isoform- and mutation-specific roles in oncogenesis
$1,539,964Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2018 · CA
Development and Preclinical Application of Pancreatic Adenocarcinoma Models
$1,539,864Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Immunobiology of Acute Environmental Asthma
$1,539,754David B Peden · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
Preclinical drug development in pancreatic cancer
$1,539,190Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
$1,538,676Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2014 · AI
Molecular Assembly and Disassembly of RNA-Protein Complexes Implicated in ALS/FTD
$1,538,408Sua Myong · Johns Hopkins University · RF1 · FY2019 · NS
Molecular mechanisms for co-transcriptional assembly of ribonucleoproteins
$1,538,184Margaret Rodgers · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
A scalable system for high-throughput and longitudinal electrophysiology in rodent brain research
$1,537,798Mattias Peter Karlsson · Spikegadgets, Llc · R44 · FY2020 · MH
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)
$1,536,996Michael Benatar · University Of Miami School Of Medicine · U54 · FY2022 · NS
Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimerâs disease and related dementias
$1,536,774Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2024 · AG
Structure-based microbially targeted prodrugs
$1,535,250Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R01 · FY2025 · AI
Development of drugs that target the M2 proton channel from the influenza A Virus
$1,535,177William F Degrado · University Of Pennsylvania · U01 · FY2009 · AI
Human pluripotent stem cells
$1,535,167Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2024 · NS
Interdisciplinary Approach to Alzheimer Drug Discovery
$1,535,008Samuel E Gandy · Icahn School Of Medicine At Mount Sinai · P01 · FY2008 · AG
A comprehensive platform for novel therapy development from the microbiome
$1,534,850Curtis Huttenhower · Broad Institute, Inc. · R24 · FY2018 · DK
Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis
$1,534,755Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · AR
Rare Disease Network for Myasthenia Gravis
$1,534,359Henry J Kaminski · George Washington University · U54 · FY2023 · NS
Malaria Drug Resistance and Disease Virulence
$1,533,622Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Reactome: An Open Knowledgebase of Human Pathways.
$1,533,353Lincoln D Stein · Ontario Institute For Cancer Research · U24 · FY2023 · HG
A comprehensive platform for novel therapy development from the microbiome
$1,532,813Curtis Huttenhower · Broad Institute, Inc. · R24 · FY2021 · DK